All regulatory updates
493 results found
Illinois enacts Public Act 104-0424 (SB2469) extending veterinarian e-prescribing exception for controlled substances
Illinois enacted Public Act 104-0424 (SB2469), amending 720 ILCS 570/311.6 (electronic prescribing for Schedule II–V controlled substances). The amendment extends the veterinarian exception to the electronic-prescribing requirement: prescriptions issued by a licensed veterinarian are not required to be electronic within 7 years after November 17, 2023 (previously 2 years). Compliance teams supporting veterinary practices and pharmacies should update EPCS compliance logic, workflows, and policy documentation to reflect the extended transition period for veterinarians under Illinois law.
EPA releases latest public TSCA Inventory update and notes next regular update planned for winter 2026
EPA announced availability of the latest update to the public (non-confidential) TSCA Inventory as part of its biannual posting cycle, including updates to inventory totals and associated data elements (e.g., commercial activity, unique identifier data, regulatory flags). EPA also notes the next regular update is planned for winter 2026. Compliance teams should refresh internal inventory reference datasets and re-check substance listing status and applicable flags used to support TSCA Inventory determinations.
EU ‘Stop-the-clock’ amendment delays Battery Regulation supply-chain due diligence application to 18 August 2027 and extends Commission guidelines deadline to 26 July 2026
A published EU amending act (“stop-the-clock”) postpones the application date of the EU Battery Regulation’s due diligence obligations to 18 August 2027 (from 18 August 2025, per the research summary). The same change also extends the deadline for the European Commission to publish due diligence guidelines to 26 July 2026 (from 18 February 2025, per the research summary). This affects compliance program timelines for in-scope economic operators required to implement battery supply-chain due diligence processes and to align internal procedures with forthcoming Commission guidance.
Louisiana SB 154 amends UCDSL to add kratom (Mitragyna speciosa) to Schedule I and creates new kratom possession/production/distribution offense
Louisiana Senate Bill 154 amends the Uniform Controlled Dangerous Substances Law to add Mitragyna speciosa (kratom) to Schedule I (R.S. 40:964) and creates new R.S. 40:966.1 establishing prohibitions on possession, cultivation/production, and distribution of kratom/kratom products. The bill also repeals R.S. 40:989.3. Compliance teams supporting regulated/pharmacy/healthcare and enforcement stakeholders should update controlled-substance screening, controlled items lists, and related SOPs/training to reflect kratom’s Schedule I status and the new standalone offense structure and penalties.
Louisiana HB 15 (2025) updates Schedule I to add N-Desethyl isotonitazene, Etonitazepipne, and Ethylphenidate (effective Aug. 1, 2025)
House Bill 15 amends R.S. 40:964 (Schedule I) under Louisiana’s Uniform Controlled Dangerous Substances Law to add N-Desethyl isotonitazene and etonitazepipne (opiates) and ethylphenidate (stimulant) to Schedule I. Compliance teams should update controlled substance master lists, intake controls, and analytical/testing panels to reflect the newly scheduled substances as of the stated effective date.
DC DLCP updates Basic Business License validity periods effective August 1, 2025
The District of Columbia Department of Licensing and Consumer Protection (DLCP) states that effective August 1, 2025, Basic Business Licenses are valid from the date of issuance to the last day of the same month two or four years later (depending on license term). Compliance teams managing vendor business license portfolios in DC should adjust renewal tracking and customer/vendor onboarding timelines to reflect the new validity/expiration convention.
AICIS varies specific information requirement (SIR) terms for 2,297 AIIC listings to add clarifying details (effective 25 July 2025)
AICIS (Executive Director) varied the terms of Australian Inventory of Industrial Chemicals (AIIC) listings for 2,297 chemicals under section 85 of the Industrial Chemicals Act 2019, specifically varying the “specific information requirement (SIR)” term. The stated purpose is to add additional information to the listings to make it easier for introducers to understand what information they must provide to AICIS. AICIS indicates the variations have no regulatory impact (i.e., obligations are not changed, but clarified/administratively detailed). Compliance teams should review whether any listed introductions they manage are among the affected chemicals and ensure internal SIR workflows and training reflect the clarified listing information.
NIOSH issues July 17, 2025 notice adding three hazardous drugs (MSHI) to Table 1 of the 2024 hazardous drug list
NIOSH posted a notice dated July 17, 2025 stating that three drugs with manufacturer’s special handling information (MSHI) are considered included in Table 1 of the NIOSH List of Hazardous Drugs in Healthcare Settings, 2024: datopotamab deruxtecan (Datroway®), treosulfan (Grafapex™), and telisotuzumab vedotin (Emrelis™). Healthcare organizations and entities aligning hazardous drug handling programs (e.g., under USP <800>) should evaluate whether these agents are handled onsite and update inventories, risk assessments, SOPs, training, engineering controls/PPE, labeling, and waste procedures accordingly.
NIOSH hazardous drugs list post-publication update adds three drugs to Table 1 via MSHI-based inclusion (July 17, 2025)
NIOSH updated the online update log for its "NIOSH List of Hazardous Drugs in Healthcare Settings, 2024" to state that certain drugs with manufacturer’s special handling information (MSHI) meeting the NIOSH definition should be treated as hazardous drugs and are considered included in Table 1. The July 17, 2025 update identifies datopotamab deruxtecan (Datroway®), treosulfan (Grafapex™), and telisotuzumab vedotin (Emrelis™) as included. This impacts healthcare and other employers’ hazardous drug handling programs (e.g., risk assessments, engineering controls, PPE, handling procedures) that rely on the NIOSH HD List.
CARB Executive Order W-25-044 approves International Code Council Evaluation Service, LLC (ICC-ES) as a CARB Third-Party Certifier (TPC-44) and supersedes EO W-23-044
CARB issued Executive Order (EO) W-25-044 approving (re-approving) International Code Council Evaluation Service, LLC (ICC-ES) as a CARB-approved Third-Party Certifier (TPC-44) under 17 CCR §93120.4 for hardwood plywood, particleboard, and medium density fiberboard. The EO supersedes EO W-23-044 and sets conditions relevant to regulated manufacturers’ ongoing use of ICC-ES for ATCM third-party certification, including subcontractor/laboratory oversight expectations and periodic reporting/recordkeeping obligations.
ASEAN Foreign Ministers’ communiqué notes decision to admit Timor-Leste as ASEAN’s 11th Member State at the 47th ASEAN Summit (October 2025)
The Joint Communiqué of the 58th ASEAN Foreign Ministers’ Meeting references the decision to admit Timor-Leste as the 11th ASEAN Member State at the 47th ASEAN Summit (October 2025), alongside efforts to expedite Timor-Leste’s accession to key ASEAN economic agreements. For compliance teams, this is an ASEAN institutional development that may affect future geographic scope of ASEAN frameworks and the applicability/rollout of ASEAN economic instruments in Timor-Leste as accession progresses.
Commission delegated rules published for recycling efficiency and material recovery calculation/verification for waste batteries
The European Commission published delegated rules under Regulation (EU) 2023/1542 establishing harmonised methodologies to calculate and verify (1) recycling efficiency for key battery chemistries (e.g., lead-acid, Ni-Cd, lithium, and “other”) and (2) material recovery (cobalt, copper, lithium, nickel, lead). The act also introduces a harmonised documentation format for recyclers to submit information to Member State authorities, affecting how recyclers and producer responsibility/compliance schemes demonstrate performance against EU Battery Regulation targets and how competent authorities can assess compliance consistently. The Commission page states the rules enter into force on 24 July 2025.
Commission publishes delegated rules on methodology to calculate/verify recycling efficiency and material recovery for waste batteries
The European Commission announced publication of delegated rules establishing a harmonised methodology to calculate and verify (1) recycling efficiency for different battery chemistries and (2) material recovery for key materials (including cobalt, copper, lithium, nickel, lead). The rules also introduce a harmonised documentation format for recycler reporting to Member State authorities. Compliance teams supporting recyclers and producer responsibility schemes should align internal calculation methods, verification evidence, and reporting documentation to the delegated methodology as of the stated entry-into-force date.
ASEAN Cosmetic Directive Annex II (prohibited substances) release updated to Version 2025-1 (dated 2 July 2025)
ASEAN Secretariat published an updated release of the ASEAN Cosmetic Directive (ACD) Annex II ‘List of substances which must not form part of the composition of cosmetic products’ (Version No. 2025-1, dated 2 July 2025). For cosmetics placed on ASEAN markets, Annex II updates are compliance-relevant because they inform ingredient screening, formulation decisions, supplier declarations, and downstream product notification/market access activities in ASEAN Member States that implement the ACD annexes via national rules. The research text notes that the PDF contains the prohibited substances list with example entries visible in the extracted text (e.g., aminophylline, theophylline, methylene chloride/dichloromethane, diethylene glycol with a trace-limit note, DEET), but does not provide a redline or explicit list of what changed versus the prior version.
Albuquerque replaces business registration with business licensing and introduces $10/day delinquency late fee (effective July 1, 2025)
The City of Albuquerque announces a shift from issuing business registrations to issuing business licenses through its online system (ABQ-PLAN), effective July 1, 2025. The city states existing registrants will transition at renewal (no immediate action; apply for a business license at renewal at no additional cost). The annual fee is stated as $35, and the city describes a delinquency structure allowing a $10/day late fee for each delinquent license if fees are not paid before starting business or before expiration. Compliance teams should ensure Albuquerque operations track renewal timing (at least 10 days before expiration per the announcement) and incorporate the new licensing terminology and late-fee exposure into compliance calendars and cost estimates.
AICIS confirms no changes to fees and levies for 2025–26; charges applied from 1 September 2025 per CRIS
AICIS published an official notice confirming there are no changes to AICIS fees and levies for the 2025–26 registration year and referenced the 2025–26 Cost Recovery Implementation Statement (CRIS). The CRIS states the regulatory charges are to be applied from 1 September 2025. This is operationally relevant for compliance budgeting and registration planning for introducers, confirming continuity in the cost recovery settings for the period.
Commission Delegated Regulation (EU) 2025/718 amends EU POPs Regulation Annex I regarding PFOS and its derivatives; some provisions apply from 3 December 2025
The European Commission adopted and published Commission Delegated Regulation (EU) 2025/718 amending Regulation (EU) 2019/1021 (EU POPs Regulation) as regards perfluorooctane sulfonic acid (PFOS) and its derivatives. The legal act specifies that certain points in the Annex apply from 3 December 2025. EU compliance teams should review the amended Annex I provisions for PFOS (including any revised concentration limits, scope, or derogations) and ensure affected products, articles, and waste streams are assessed against the updated requirements by the stated application date.
Commission Delegated Regulation (EU) 2025/718 amends EU POPs Regulation Annex I regarding PFOS; some provisions apply from 3 Dec 2025
The European Commission adopted and published Commission Delegated Regulation (EU) 2025/718 amending Annex I of Regulation (EU) 2019/1021 (EU POPs Regulation) as regards PFOS and its derivatives. The delegated act is published in the Official Journal (OJ L, 2025/718, 27.6.2025) and enters into force 20 days after publication; however, the act specifies delayed applicability for parts of the Annex (points 2 and 3) from 3 December 2025. Compliance teams should review the revised Annex I PFOS provisions, ensure product/material and waste streams are assessed against the updated PFOS requirements, and plan for controls applicable from 3 Dec 2025 as stated in the act.
ECHA decision confirms SVHC identifications and Candidate List publication/update on 25 June 2025 (incl. Reactive Brown 51 and two siloxanes)
ECHA issued Decision D(2025)4165-DC confirming identification of certain substances as SVHCs and stating that ECHA shall publish and update the REACH Candidate List on 25 June 2025; the decision takes effect from 25 June 2025. The decision text cited in the research identifies, among others, Reactive Brown 51 (Repr. 1B; Article 57(c)) and the siloxanes 1,1,1,3,5,5,5-heptamethyl-3-[(trimethylsilyl)oxy]trisiloxane and decamethyltetrasiloxane (vPvB; Article 57(e)). For compliance teams, this triggers standard Candidate List obligations (e.g., article communication and SCIP where applicable) from the inclusion/publication date stated in the decision.
ECHA updates REACH SVHC Candidate List: three substances added (total 250 entries)
On 25 June 2025, ECHA updated the REACH SVHC Candidate List by adding three new SVHC entries, bringing the total to 250 entries. The additions cited in the research data are: 1,1,1,3,5,5,5-heptamethyl-3-[(trimethylsilyl)oxy]trisiloxane (EC 241-867-7; CAS 17928-28-8) identified as vPvB (Article 57(e)); decamethyltetrasiloxane (EC 205-491-7; CAS 141-62-8) identified as vPvB (Article 57(e)); and Reactive Brown 51 (EC 466-490-7) identified as toxic for reproduction (Article 57(c)). Compliance teams should assess whether these SVHCs are present in substances, mixtures, or articles and implement Candidate List-related duties (e.g., communication for SVHCs in articles above 0.1% w/w and related supply-chain disclosures) in line with ECHA’s Candidate List obligations messaging.